Our study provides a basis for the development of a novel biomarker for the diagnosis and prognosis of gastric cancer. Acknowledgments Work was supported by Zhejiang Provincial Department of Science and Technology Research Foundation (2008C33040), and Zhejiang Provincial Medical Science Research Foundation (this website 201337120). References 1. Lee HS, Lee HK, Kim HS,

et al.: Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 2003, 200:39–46.PubMedCrossRef 2. Lee HS, Lee HK, Kim HS, et al.: MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 2001, 92:1427–34.PubMedCrossRef 3. Kolev Y, Uetake H, Iida S, et al.: Prognostic significance of VEGF expression in correlation with COX-2, microvessel density and clinicopathological characteristics Necrostatin-1 concentration in human gastric carcinoma. Ann Surg Oncol 2007, 14:2738–47.PubMedCrossRef 4. Mizokami K, Kakeji Y, Oda S, et al.: Clinicopathologic significance of hypoxia-inducible factor 1 alpha overexpression in gastric carcinomas. J Surg Oncol 2006, 94:149–154.PubMedCrossRef

5. Song LB, Liao WT, Mai HQ, et al.: The clinical significance of twist expression in nasopharyngeal carcinoma. Cancer Lett 2006, 242:258–65.PubMedCrossRef 6. Geisler SA, Olshan AF, Weissler MC, et al.: p16 and p53 protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 2002, 8:3445–53.PubMed

7. Thiamet G Fukuoka J, Fujii T, Shih JH, et al.: Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin Cancer Res 2004, Selleckchem PRI-724 10:4314–24.PubMedCrossRef 8. Shiraishi N, Sato K, Yasuda K, et al.: Multivariate prognostic study on large gastric cancer. J Surg Oncol 2007, 96:14–18.PubMedCrossRef 9. Raveh S, Gavert N, Ben-Ze’ev A: L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett 2009,282(2):137–45.PubMedCrossRef 10. Gavert N, Ben-Shmuel A, Raveh S, Ben-Ze’ev A: L1-CAM in cancerous tissues. Expert Opin Biol Ther 2008,8(11):1749–57.PubMedCrossRef 11. Rawnaq T, Kleinhans H, Uto M, et al.: Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma. Anticancer Res 2009,29(4):1195–9.PubMed 12. Bergmann F, Wandschneider F, Sipos B, et al.: Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma. Oncol Rep 2010,24(4):909–15.PubMed 13. Ben QW, Wang JC, Liu J, et al.: Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma. Ann Surg Oncol 2010,17(8):2213–21.PubMedCrossRef 14. Kajiwara Y, Ueno H, Hashiguchi Y, et al.: Expression of l1 cell adhesion molecule and morphologic features at the invasive front of colorectal cancer. Am J Clin Pathol 2011,136(1):138–44.PubMedCrossRef 15. Choi SY, Jo YS, Huang SM, et al.